TREACE MEDICAL CONCEPTS, INC. (TMCI) has 124 open-market insider trades by 18 insiders since 2009. Over the last six months insiders net bought $1.5M. The most active filer is John T. Treace, CEO & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| John T. Treace | CEO10% Owner | — | 25 | $107.9M | 2026-08-24 |
| F. Barry Bays | — | — | 18 | $73.1M | 2023-06-05 |
| James T. Treace | Dir | — | 25 | $19.1M | 2024-08-15 |
| Richard W. Mott | Dir | — | 16 | $17.6M | 2025-05-20 |
| Thomas E. Timbie | Dir | — | 9 | $10.9M | 2023-03-15 |
| John R. Treace | Dir | — | 2 | $7.9M | 2022-05-09 |
| Jaime A. Frias | — | — | 1 | $5.6M | 2022-03-08 |
| Sean F. Scanlan | — | — | 9 | $4.9M | 2026-08-09 |
| John K. Bakewell | Dir | — | 1 | $594K | 2026-05-19 |
| Daniel E. Owens | — | — | 5 | $442K | 2023-03-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| John T. Treace | CEO & 10% Owner | Buy | $247K | 2026-08-20 |
| John T. Treace | CEO & 10% Owner | Buy | $211K | 2026-06-10 |
| John T. Treace | CEO & 10% Owner | Buy | $99K | 2026-06-10 |
| John T. Treace | CEO & 10% Owner | Buy | $178K | 2026-06-01 |
| John T. Treace | CEO & 10% Owner | Buy | $341K | 2026-05-26 |
| John T. Treace | CEO & 10% Owner | Buy | $376K |
Companies that share insiders with TMCI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-05-12 |
| Sean F. Scanlan | — | Sell | $399K | 2025-03-17 |
| John T. Treace | CEO | Buy | $524K | 2025-03-04 |
| John T. Treace | CEO | Buy | $266K | 2024-09-16 |
| James T. Treace | Director | Buy | $501K | 2024-08-15 |
| John T. Treace | CEO | Buy | $510K | 2024-08-14 |
| John T. Treace | CEO | Buy | $265K | 2024-06-11 |
| James T. Treace | Director | Buy | $151K | 2024-05-31 |
| James T. Treace | Director | Buy | $130K | 2024-05-29 |
| James T. Treace | Director | Buy | $254K | 2024-05-28 |